|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
See Header: Other general symptoms and signs
ICD-10 (CM) Code and Descriptor
|
R68.89 |
Other general symptoms and signs
|
R6889 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 21.51%
|
22.00%
|
17.57%
|
12.30%
|
8.58%
|
5.72%
|
3.64%
|
2.65%
|
1.85%
|
1.25%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R68.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
97110
|
THERAPEUTIC EXERCISES |
19,545
|
35,308
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
18,631
|
18,667
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
16,032
|
16,034
|
|
80053
|
COMPREHEN METABOLIC PANEL |
12,664
|
12,665
|
|
97530
|
THERAPEUTIC ACTIVITIES |
12,147
|
20,756
|
|
84443
|
ASSAY THYROID STIM HORMONE |
9,229
|
9,235
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
6,322
|
6,335
|
|
80048
|
METABOLIC PANEL TOTAL CA |
5,620
|
5,624
|
|
80061
|
LIPID PANEL |
4,731
|
4,731
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
4,434
|
6,671
|
|
85027
|
COMPLETE CBC AUTOMATED |
4,295
|
4,295
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
3,916
|
3,917
|
|
97140
|
MANUAL THERAPY 1/> REGIONS |
3,582
|
4,634
|
|
82607
|
VITAMIN B-12 |
3,549
|
3,549
|
|
97535
|
SELF CARE MNGMENT TRAINING |
3,457
|
5,720
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
3,225
|
3,227
|
|
97116
|
GAIT TRAINING THERAPY |
2,836
|
3,299
|
|
82306
|
VITAMIN D 25 HYDROXY |
2,820
|
2,820
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
2,760
|
2,765
|
|
U0005
|
INFEC AGEN DETEC AMPLI PROBE |
2,616
|
2,616
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R68.89 related to the following DRG Codes:
947-948
|
